Evidence map›Paper›PMID 31928139›Full record

ReviewTissue engineering. Part B, Reviews2020

Histological Review of Demineralized Dentin Matrix as a Carrier of rhBMP-2.

In-Woong Um, Jeong-Kui Ku, Young-Kyun Kim, Bu-Kyu Lee, Dae Ho Leem

Open access · hybridAbstract readReview
In one paragraph

Review in Tissue engineering. Part B, Reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Application of collagen in bone regeneration.Journal of orthopaedic translation · 2025
    Review
  15. Review
  16. Comparison of the osteogenic effects of demineralized dentin matrix and acellular dentin matrix.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

In-Woong UmR&D Institute, Korea Tooth Bank, Seoul, Republic of Korea.
Jeong-Kui KuSection of Dentistry, Department of Oral and Maxillofacial Surgery, Armed Forces Capital Hospital, Seongnam, Republic of Korea.
Young-Kyun KimSection of Dentistry, Department of Oral and Maxillofacial Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Bu-Kyu LeeDepartment of Oral and Maxillofacial Surgery, Seoul Asan Medical Center, Seoul, Republic of Korea.
Dae Ho LeemDepartment of Oral and Maxillofacial Surgery, School of Dentistry and Institute of Oral Bioscience, Research Institute of Clinical Medicine of Chonbuk National University, Jeonju, Republic of Korea.
Armed Forces Capital Hospital · KRAsan Medical Center · KRBank of Korea · KRJeonbuk National University · KRSeoul National University Bundang Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2007, recombinant human bone morphogenetic protein-2 (rhBMP-2) was approved for use in humans at a concentration of 1.5 mg/mL with absorbable collagen sponges as an alternative to autogenous bone grafts for alveolar ridge augmentation, defects associated with extraction sockets, and sinus augmentation. However, the use of supraphysiological doses and the insufficient retention of rhBMP-2, when delivered through collagen sponge, result in dose-dependent side effects related to off-label use. Demineralized dentin matrix (DDM), an osteoinducing bone substrate, has been used as an rhBMP-2 carrier since 1998. In addition, DDM has both microparticle and nanoparticle structures, which do not undergo remodeling, unlike bone.

Indexed as

Alveolar ProcessAnimalsBone Morphogenetic Protein 2DentinHumansProstheses and ImplantsRecombinant ProteinsTransforming Growth Factor betaBone Morphogenetic Protein 2Demineralized Dentin Matrixrecombinant human bone morphogenetic protein-2Recombinant ProteinsTransforming Growth Factor betabone morphogenetic proteinbone substitutedemineralized dentin matrix

Identifiers

PMID31928139
PMCPMC7310192
OpenAlexW2999431893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.